Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine for Mood Disorders in Adolescents
NCT00221468Phase 3Completed
- Sponsor
- University of Cincinnati
- Start
- Jun 2003
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind, single-arm trial of quetiapine in mood disorder, sponsored by University of Cincinnati. Primary endpoint: Clinical Global Impression Improvement at 12 weeks. Started Jun 2003; status: completed.
02
Drugs
quetiapine
03
Conditions
mood disorder
Beyond the preview
Go deeper on NCT00221468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00221468.